Big Pharma Quality - Customized Approach! Pillar5 Pharma Inc. provides access to safe medications through various partners as a Contract Manufacturing Organization (CMO). Offering excellence in: operations; quality; business; and customer service. Expertise in: solid dose, ophthalmics and analytical services. Further to the acquisition of the former Pfizer plant, this plant has been in operation since 1956. It has also been successfully inspected by Health Canada in 2012 and the FDA in 2013 (no 483's).
James E. Gregory, UPM Pharmaceuticals||October 7, 2015 Pharmaceutical and biopharmaceutical companies large and small are increasingly relying on third-party providers for support at all stages of drug development. To realize efficiencies, they are at the same time reducing the number of suppliers to a preferred few with whom they can form strategic partnerships.
Franklin Spriggs, Stephanie Mowery and Bo Kowalcyk, AIT Bioscience ||October 7, 2015 ADCs are a breakthrough cancer treatment that can deliver cytotoxins directly to cancer cells without the sweeping collateral damage of traditional chemotherapy.
Suhasini Sharma, Sciformix Corporation ||September 11, 2015 Global biologics market will expand to $250 billion annually by 2020, with biosimilars and non-original biologics commanding 4-10% of that market